We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Risk Factor Identified for Gastrointestinal Disorder in Neonates

By LabMedica International staff writers
Posted on 08 Dec 2011
A major risk factor has been identified in premature infants who suffer from the life-threatening destruction of intestinal tissue.

Premature newborns that develop the medical condition called necrotizing enterocolitis (NEC), and have the AB blood type are nearly three times as likely to die from it as preemies with other blood types. More...


Doctors at Loyola University Medical Center (Maywood, IL, USA) examined records of 276 preemies in their neonatal intensive care unit (ICU) who suffered severe NEC during the last 24 years. Preemies often require multiple blood transfusions. Neonatal ICUs typically give Type O, the universal donor type, but this practice may inadvertently cause an enhanced immune reaction. This reaction, in turn, could be a reason why AB babies who develop NEC have a higher mortality.

The investigators found that AB preemies were 2.87 times more likely to die from NEC than babies with other blood types were. The significant difference in survival within the group of AB neonates is not only due to the disproportionate frequency of their demise (43%), but also to their short survival times. NEC likely involves several factors, including a decrease in blood flow to the bowel, infection, mechanical injury, and abnormal immune response. NEC occurs when the lining of the intestinal wall dies and tissue falls off. Most cases of NEC are mild to moderate and can be successfully treated with antibiotics. However, in severe cases, a hole can develop in the intestine, allowing bacteria to leak into the abdomen and causing a life-threatening infection.

The investigators suggested it may be prudent to change transfusion practices so that preemies receive their specific blood types, rather than the universal donor Type O. Jonathan Muraskas, MD, senior author of the study said "Although this will likely not eradicate NEC, it is an easily modifiable factor that may help to prevent those cases of NEC that develop in relation to the transfusion of blood products". The study was published on November 17, 2011, in the Journal of Perinatology.

Related Links:

Loyola University Medical Center


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.